ESPACOLASER (ESPA3) Main Indicators
Basic Data - ESPA3
| Company | ESPACOLASER |
| Corporate Name | MPM CORPÓREOS S.A. |
| Registration Status | ATIVO |
| Issuer Status | FASE OPERACIONAL |
| Listing Segment | Novo Mercado |
| Activity | Participação como sócia de sociedades empresárias que desenvolvam atividades de depilação. estética facial. capilar e corporal e a comercialização de produtos cosméticos e de cuidados corporais. |
| Share | ESPA3 |
| Quote Date | 11/19/2024 |
| Share Type | ON |
| Last Closing | R$ 0.94 |
| Quotation Factor | 1 Share |
| Financial Volume | R$ 494.83 thousand |
| Last Statement | ITR - 09/30/2024 |
| Sector | Consumo Cíclico |
| Subsector | Comércio |
| Segment | Produtos Diversos |
| Participation Indexes | IGC, IGNM, ITAG |
| Updated 11/21/2024 | |
Relative Prices - ESPA3
| Price/Earnings | -16.18 |
| Price/SBV | 0.40 |
| Price/Net Sales | 0.33 |
| Price/CFO | 4.02 |
| Price/FCF | 4.98 |
| Price/Total Assets | 0.15 |
| Price/EBIT | 2.46 |
| Price/Working Capital | 0.98 |
| Price/NCAV | -0.34 |
| EV/EBIT | 7.33 |
| EV/EBITDA | 4.44 |
| EV/Net Sales | 0.98 |
| EV/CFO | 11.98 |
| EV/FCF | 14.83 |
| EV/Total Assets | 0.46 |
| Company Market Cap | R$ 339.74 M |
| Enterprise Value | R$ 1.01 B |
| Current Financial Statement Date | 09/30/2024 |
| Current Share Price | R$ 0.94 |
| Share Price Date | 11/19/2024 |
| Dividend Yield | 0.00% |
| Updated 11/21/2024 | |
Income Statement - ESPA3
| Net Revenue | R$ 1.03 B |
| Gross Result | R$ 391.37 M |
| EBIT | R$ 138.02 M |
| Depreciation and Amortization | - R$ 89.87 M |
| EBITDA | R$ 227.89 M |
| Net Profit | - R$ 20.99 M |
| Net Profit/Share | - R$ 0.06 |
| Updated 11/07/2024 | |
| Net Revenue | R$ 237.51 M |
| Gross Result | R$ 68.63 M |
| EBIT | R$ 27.16 M |
| Depreciation and Amortization | - R$ 23.35 M |
| EBITDA | R$ 50.50 M |
| Net Profit | - R$ 9.66 M |
| Profit/Share | - R$ 0.03 |
| Updated 11/07/2024 | |
Price and Volume Behavior - ESPA3
| Lowest Price 52 weeks | R$ 0.88 |
| Highest Price 52 weeks | R$ 1.41 |
| Variation 2024 | -18.26% |
| Variation 1 year | -32.86% |
| Variation 2 years(total) | -34.27% |
| Variation 2 years(yearly) | -18.88% |
| Variation 3 years(total) | -90.17% |
| Variation 3 years(yearly) | -53.81% |
| Variation 4 years(total) | - |
| Variation 4 years(yearly) | - |
| Variation 5 years(total) | - |
| Variation 5 years(yearly) | - |
| Average Daily Volume (3 months) | R$ 284.14 thousand |
| Updated 11/21/2024 | |
Returns and Margins - ESPA3
| Return on Initial Tangible Capital | 11.00% |
| Return on Initial Invested Capital | 5.81% |
| Pre-Tax Return on Initial Tangible Capital | 16.67% |
| Pre-Tax Return on Initial Invested Capital | 8.80% |
| Return on Initial Shareholder´s Equity | -2.39% |
| Return on Initial Asset | -0.92% |
| Gross Margin | 38.06% |
| Net Margin | -2.04% |
| EBIT Margin | 13.42% |
| EBITDA Margin | 22.16% |
| Initial Asset Turnover | 0.45 |
| Financial Leverage | 2.57 |
| Liabilities/Net Worth | 1.57 |
| Net Debt/EBITDA | 2.95 |
| Updated 11/07/2024 | |
Balance Sheet - ESPA3
| Cash and Cash Equivalents | R$ 182.78 M |
| Total Assets | R$ 2.20 B |
| Short-Term Debt | R$ 162.95 M |
| Long-Term Debt | R$ 691.96 M |
| Gross Debt | R$ 854.92 M |
| Net Debt | R$ 672.14 M |
| Shareholder´s Equity | R$ 854.91 M |
| Share Book Value | R$ 2.37 |
| Common Shares | 361,423,066 |
| Preferred Shares | 0 |
| Total | 361,423,066 |
| Common Shares in Treasury | 0 |
| Preferred Shares in Treasury | 0 |
| Total in Treasury | 0 |
| Common Shares (Except Treasury) | 361,423,066 |
| Preferred Shares (Except Treasury) | 0 |
| Total (Except Treasury) | 361,423,066 |
| Updated 11/07/2024 | |
Cash Flow - ESPA3
| Operating Cash Flow | R$ 84.46 M |
| Cash Flow from Investments | - R$ 21.16 M |
| Financing Cash Flow | - R$ 102.85 M |
| Increase (Reduction) in Cash and Equivalents | - R$ 39.55 M |
| Updated 11/07/2024 | |
| Operating Cash Flow | R$ 27.34 M |
| Cash Flow from Investments | - R$ 4.64 M |
| Financing Cash Flow | - R$ 12.14 M |
| Increase (Reduction) in Cash and Equivalents | R$ 10.56 M |
| Updated 11/07/2024 | |
Experimental - ESPA3
| CAPEX 3 months | - R$ 756.00 thousand |
| Free Cash Flow 3 months | R$ 26.58 M |
| CAPEX 12 months | - R$ 16.25 M |
| Free Cash Flow 12 months | R$ 68.21 M |
| Updated 11/07/2024 | |